ABC 6
An ABC6 story profiles lung cancer patients who are taking part in an Abramson Cancer Center trial for the drug crizotinib, which targets a gene that promotes tumor growth, typically among younger, non-smoking patients. The patients in the story say they have seen dramatic responses -- tumor shrinkage as well as a reduction in symptoms like coughing... Read More
Related Information